Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/50559
Campo DC Valoridioma
dc.contributor.authorTorres, Fernandoen_US
dc.contributor.authorQuintana, Joséen_US
dc.contributor.authorEstévez, Franciscoen_US
dc.contributor.otherQuintana, Jose-
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherTorres Andon, Fernando-
dc.date.accessioned2018-11-24T16:59:34Z-
dc.date.available2018-11-24T16:59:34Z-
dc.date.issued2010en_US
dc.identifier.issn0899-1987en_US
dc.identifier.urihttp://hdl.handle.net/10553/50559-
dc.description.abstractFlavonoids are polyphenolic compounds which display a vast array of biological activities and are promising anticancer agents. In this study we investigated the effect of 5,7,3′-trihydroxy-3,4′-dimethoxyflavone (THDF) on viability of nine human tumor cell lines and found that it was highly cytotoxic against leukemia cells. THDF induced G2-M phase cell-cycle arrest and apoptosis through a caspase-dependent mechanism involving cytochrome c release, processing of multiple caspases (caspase-3, -6, -7, and -9) and cleavage of poly(ADP-ribose) polymerase. Overexpression of the protective mitochondrial proteins Bcl-2 and Bcl-xL conferred partial resistance to THDF-induced apoptosis. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases (MAPKs) family and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress-activated protein kinases (JNK/SAPK) and of extracellular signal-regulated kinases (ERK) 1/2. In the present study we report that THDF-induced cell death is mediated by an intrinsic dependent apoptotic event involving mitochondria and MAPKs, and through a mechanism independent of the generation of reactive oxygen species. The results suggest that THDF could be useful in the development of novel anticancer agents.en_US
dc.languageengen_US
dc.relationDesarrollo de Nuevos, Mas Seguros y Mas Efectivos Compuestos Antileucemicosen_US
dc.relationEvaluación de Tdf Como Potencial Fármaco Antitumoral.en_US
dc.relation.ispartofMolecular Carcinogenesisen_US
dc.sourceMolecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475 (Mayo 2010)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320703 Carcinogénesisen_US
dc.subject.otherG(2)-M Phase Arresten_US
dc.subject.otherDifferential Regulationen_US
dc.subject.otherSignal-Transductionen_US
dc.subject.otherInduced Apoptosisen_US
dc.subject.otherMammalian-Cellsen_US
dc.subject.otherCancer Cellsen_US
dc.subject.otherJnken_US
dc.subject.otherQuercetinen_US
dc.subject.otherKinaseen_US
dc.subject.otherInhibitionen_US
dc.title5,7,3′-trihydroxy-3,4′-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathwayen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/mc.20619en_US
dc.identifier.scopus77953033838-
dc.identifier.isi000277311800004-
dcterms.isPartOfMolecular Carcinogenesis-
dcterms.sourceMolecular Carcinogenesis[ISSN 0899-1987],v. 49 (5), p. 464-475-
dc.contributor.authorscopusid55366045300-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid7003810011-
dc.description.lastpage475en_US
dc.identifier.issue5-
dc.description.firstpage464en_US
dc.relation.volume49en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000277311800004-
dc.contributor.daisngid34941095-
dc.contributor.daisngid2952604-
dc.contributor.daisngid128315-
dc.contributor.daisngid384944-
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDD-5184-2009-
dc.description.numberofpages12en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Torres, F-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Estevez, F-
dc.date.coverdateMayo 2010en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr3,265-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.project.principalinvestigatorEstévez Rosas, Francisco Jesús-
crisitem.project.principalinvestigatorQuintana Aguiar, José Martín-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

27
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

26
actualizado el 17-nov-2024

Visitas

53
actualizado el 02-dic-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.